These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1799664)

  • 1. Treatment of the severe bleeding episode in type III von Willebrand's disease by simultaneous administration of cryoprecipitate and platelet concentrate.
    Boda Z; Pfliegler G; Hársfalvi J; Rak K
    Blood Coagul Fibrinolysis; 1991 Dec; 2(6):775-7. PubMed ID: 1799664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo interaction of von Willebrand factor with platelets following cryoprecipitate transfusion in platelet-type von Willebrand's disease.
    Miller JL; Boselli BD; Kupinski JM
    Blood; 1984 Jan; 63(1):226-30. PubMed ID: 6418233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment of severe hemorrhage by using thrombocyte suspension with cryoprecipitate in type III Willebrand disease].
    Boda Z; Pfliegler G; Hársfalvi J; Rák K
    Orv Hetil; 1991 Nov; 132(45):2499-502. PubMed ID: 1945395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates.
    Gazengel C; Fischer AM; Schlegel N; Rothschild C; Torchet MF; Dautzenberg MD; Aujard Y
    Nouv Rev Fr Hematol (1978); 1988; 30(4):225-7. PubMed ID: 3143100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens and surgery in women with von Willebrand's disease.
    Alperin JB
    Am J Med; 1982 Sep; 73(3):367-71. PubMed ID: 6981997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-treated factor VIII/von Willebrand factor concentrate in platelet-type von Willebrand's disease.
    Takahashi H; Tatewaki W; Nagayama R; Hanano M; Tamura M; Yamaguchi T; Takizawa S; Wada K; Shibata A
    Haemostasis; 1987; 17(6):353-60. PubMed ID: 3123334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the prolonged bleeding time in von Willebrand's disease.
    Smiley RK; Tittley P; Rock G
    Thromb Res; 1989 Mar; 53(5):417-26. PubMed ID: 2499940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.
    Sultan Y; Simeon J; Maisonneuve P; Caen JP
    Thromb Haemost; 1976 Feb; 35(1):110-9. PubMed ID: 1085498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a high-purity factor VIII concentrate (Hemate P) in von Willebrand's disease.
    Berntorp E; Nilsson IM
    Vox Sang; 1989; 56(4):212-7. PubMed ID: 2503935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease.
    Ching YN; Meyers KM; Brassard JA; Wardrop KJ
    Am J Vet Res; 1994 Jan; 55(1):102-10. PubMed ID: 8141483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of fresh-frozen plasma and cryoprecipitate in dogs with von Willebrand's disease or hemophilia A.
    Stokol T; Parry B
    J Vet Intern Med; 1998; 12(2):84-92. PubMed ID: 9560764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of AHF concentration to control bleeding in von Willebrand's disease.
    Green D; Potter EV
    Am J Med; 1976 Mar; 60(3):357-60. PubMed ID: 1083144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand's disease.
    Green D
    Postgrad Med; 1980 Mar; 67(3):241-5, 248. PubMed ID: 6965541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-type von Willebrand's disease.
    Miller JL
    Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A rare hemostatic disorder: pseudo von Willebrand's disease].
    Monrigal C; Fressinaud E; Shoay I; Monrigal JP; Granry JC
    Ann Fr Anesth Reanim; 1989; 8(6):662-6. PubMed ID: 2517382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet function and immunologic parameters in von Willebrand's disease following cryoprecipitate and factor VIII concentrate infusion.
    Chediak JR; Telfer MC; Green D
    Am J Med; 1977 Mar; 62(3):369-76. PubMed ID: 300224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.